SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-023860
Filing Date
2020-05-11
Accepted
2020-05-11 07:50:20
Documents
46
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q wve-10q_20200331.htm   iXBRL 10-Q 1251051
2 EX-31.1 wve-ex311_8.htm EX-31.1 14708
3 EX-31.2 wve-ex312_6.htm EX-31.2 15036
4 EX-32 wve-ex32_9.htm EX-32 8863
5 GRAPHIC g4aqyly042o4000001.jpg GRAPHIC 38883
  Complete submission text file 0001564590-20-023860.txt   3596519

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA wve-20200331.xsd EX-101.SCH 29934
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20200331_cal.xml EX-101.CAL 33865
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20200331_def.xml EX-101.DEF 90906
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20200331_lab.xml EX-101.LAB 241737
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20200331_pre.xml EX-101.PRE 171902
40 EXTRACTED XBRL INSTANCE DOCUMENT wve-10q_20200331_htm.xml XML 320771
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 20862652
SIC: 2834 Pharmaceutical Preparations